BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Operating cash flow (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $2.9B | +36.0% | −12.2% | −5.6% |
| Operating cash flow (TTM) | $2.9B |
|---|---|
| YoY | +36.0% |
| 5-year CAGR | −12.2% |
| 10-year CAGR | −5.6% |
Operating cash flow
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $2.2B | −23.3% |
| 2024 | $2.9B | +85.9% |
| 2023 | $1.5B | +11.8% |
| 2022 | $1.4B | −62.0% |
| 2021 | $3.6B | −13.9% |
| 2020 | $4.2B | −40.2% |
| 2019 | $7.1B | +14.4% |
| 2018 | $6.2B | +36.0% |
| 2017 | $4.6B | −0.8% |
| 2016 | $4.6B | +17.0% |
| 2015 | $3.9B | +33.2% |
| 2014 | $2.9B | +25.5% |
| 2013 | $2.3B | +24.7% |
| 2012 | $1.9B | +8.8% |
| 2011 | $1.7B | +6.3% |
| 2010 | $1.6B | +51.1% |
| 2009 | $1.1B | −31.2% |
| 2008 | $1.6B | +53.4% |
| 2007 | $1.0B | — |